Balyasny Asset Management L.P.

Position in PACB — Pacific Biosciences Of California, Inc.

CIK 1218710 Chicago, IL

Back to PACB Full portfolio

Position in PACB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$948,089

+$604,179 QoQ

Shares Held

564,339

+116.6% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 222 holders

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PACB Over Time

Shares Held

Position Value (USD)

Derivatives in PACB

reported options exposure · as of Jun 30, 2022

CallValue

$110,500

CallShares

25,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names. PACB ranks #21 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	1,090,163	$344,218,967
2	MDT	Medtronic plc	986,367	$77,163,489
3	GKOS	GLAUKOS Corp	491,636	$68,711,047
4	ABT	Abbott Laboratories	740,808	$67,220,917
5	EW	Edwards Lifesciences Corp	456,202	$41,268,032
6			739,829	$18,406,945
7	BBNX	Beta Bionics, Inc.	855,682	$13,408,536
8	AXGN	Axogen, Inc.	253,498	$11,709,072

All Filings in PACB

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$948,089	564,339	+116.6%	Shares	Sole	2026-08-14
2026-03-31	$343,910	260,538	-9.7%	Shares	Sole	2026-05-15
2024-03-31	$1,082,295	288,612	-11.7%	Shares	Sole	2024-05-13
2023-09-30	$2,728,529	326,770	-6.5%	Shares	Sole	2023-11-14
2022-12-31	$2,858,018	349,391	+1228.0%	Shares	Sole	2023-02-14
2022-06-30	$110,500	25,000	—	Call	Sole	2022-08-15
2021-12-31	$538,282	26,309	+38.3%	Shares	Sole	2022-02-14
2020-06-30	$65,650	19,029	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.